Error: Could not add to watchlist. X

BB Adamant Global Medtech und

+ Watchlist
ADAGMED:SW
1,726.25
CHF
15.58
0.91%
As of 12:10:00 ET on 06/30/2015.
Volume
0
Previous Close
1,710.67
52Wk Range
1,256.32 - 1,806.79
1 Yr Return
35.86%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/30/2015)
1,726.25
Total Assets (m CHF) (on 06/30/2015)
110.050
Inception Date
03/03/2008
Last Dividend (on 12/05/2012)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
2.50%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.81%
Expense Ratio
1.84%
Top Fund Holdings
Name Position Value % of Fund
UnitedHealth Group Inc 115.00 k 12.39 m 10.98
Medtronic PLC 130.00 k 9.56 m 8.47
Abbott Laboratories 173.00 k 7.77 m 6.88
Express Scripts Holding Co 80.00 k 6.43 m 5.70
Cigna Corp 52.00 k 6.00 m 5.31
McKesson Corp 26.00 k 5.64 m 4.99
Aetna Inc 59.00 k 5.57 m 4.93
Humana Inc 30.00 k 4.67 m 4.14
HCA Holdings Inc 67.00 k 4.54 m 4.03
Baxter International Inc 65.00 k 4.26 m 3.78
Profile
BB Adamant Global Medtech und Services is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the medicinal sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050